A new record for a Natroba clinical trial is available on the US Clinical Trials registry.

A short overview of pediculosis clinical trials in recent years.

New research has been released investigating the effectiveness of two natural substances, tea tree oil and nerolidol, against head lice and eggs, suggesting high levels of pediculicidal and ovicidal activity.

New data has been released this month which claims in vivo effectiveness for a non-pesticide based head-lice treatment.

A recent paper in the International Journal of Dermatology has proposed guidelines and protocols for clinical trials of pediculicides.

The US Food and Drug Administration (FDA) have been urged to prevent the use of lindane in topical pediculosis treatments for children.

The Fifth International Conference of Phthiraptera will take place between 2-7 August 2014 in Utah, USA.

An updated version of the FDA-approved Sklice clinical trial has been published on the ClinicalTrials.gov website.

A recent publication focussing on novel potential physically-acting anti-lice treatments has identified the surfactant 1,2-octanediol as an effective pediculicide in both in vitro and in vivo studies.

A recent full-gene comparison between body lice and head lice has demonstrated that their genomes are close enough to be classed as the same species.